Conclusion
The results of this study reflect the influence of demographic, clinical characteristics and technology of the children receiving NIV on long-term therapy outcomes particularly age, diagnostic category and specific underlying conditions, added comorbidities and technologies in use and technology type. These results are important for clinicians, as they can use available information to discuss goals and expectations of NIV with children and families even prior to NIV initiation and optimize resources to ensure adequate follow up management and improve the success children may achieve using NIV therapy.